These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7904329)

  • 1. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Zbrozek AS
    N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 7904329
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Goldschmidt RH; Hearst N; Chambers DB
    N Engl J Med; 1994 Feb; 330(6):436-7; author reply 438. PubMed ID: 7904328
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifabutin prophylaxis against Mycobacterium avium complex disease.
    Goldschmidt RH; Dong BJ
    J Am Board Fam Pract; 1994; 7(1):80-3. PubMed ID: 7907837
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    von Reyn CF; Brown ST; Arbeit RD
    N Engl J Med; 1994 Feb; 330(6):437; author reply 438. PubMed ID: 8129826
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis of Mycobacterium avium complex infections in AIDS.
    Klaus BD
    Nurse Pract; 1995 Jun; 20(6):80-1. PubMed ID: 7659325
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new prophylactic agent in AIDS: Ansatipine. Disseminated Mycobacterium avium complex infection is now the most frequent of the opportunistic bacterial infections in AIDS].
    Dautzenberg B
    Allerg Immunol (Paris); 1994 Apr; 26(4):141-4. PubMed ID: 8031459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The stakes in preventing opportunistic MAI infections in AIDS. From an interview with Dr. Patrick Philibert].
    Philibert P
    Allerg Immunol (Paris); 1994 Apr; 26(4):145-8. PubMed ID: 7913323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifabutin prophylaxis and uveitis.
    Fuller JD; Stanfield LE; Craven DE
    N Engl J Med; 1994 May; 330(18):1315-6. PubMed ID: 8145794
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluconazole and enhanced effect of rifabutin prophylaxis.
    Narang PK; Trapnell CB; Schoenfelder JR; Lavelle JP; Bianchine JR
    N Engl J Med; 1994 May; 330(18):1316-7. PubMed ID: 7695673
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Reichman LB; McDonald RJ; Mangura BT
    N Engl J Med; 1994 Feb; 330(6):437-8. PubMed ID: 8129827
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
    Masur H
    N Engl J Med; 1993 Sep; 329(12):898-904. PubMed ID: 8395019
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment review. Rifabutin.
    Co M
    J Assoc Nurses AIDS Care; 1994; 5(1):45-50. PubMed ID: 8167311
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifabutin prophylaxis against Mycobacterium avium complex infection.
    Nightingale SD
    Lancet; 1995 Jan; 345(8944):265. PubMed ID: 7823751
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis.
    Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T
    AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex.
    Böttger EC; Wallace RJ
    Lancet; 1994 Nov; 344(8935):1506-7. PubMed ID: 7734014
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection.
    Maslo C; Buré-Rossier A; Girard PM; Gholizadeh Y; Lebrette MG; Rozenbaum W
    Clin Infect Dis; 1997 Mar; 24(3):344-9. PubMed ID: 9114183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAC prophylaxis revisited.
    Torres G
    GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.